• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Now accepting nominations for the Fierce Innovation Awards - Submit your application today

CagriSema

Karsten Munk Knudsen Novo Nordisk
Biotech

Novo Nordisk’s CFO reflects on ‘pressure’ to drive growth

Novo Nordisk’s CFO spoke to Fierce the morning the company unveiled its second-quarter earnings, reflecting on its “roller coaster” financial journey.
James Waldron Aug 7, 2026 9:08am
Podcast
The Top Line TTL 2023

Novo Nordisk’s CFO on the oral Wegovy rollout and beyond

Aug 7, 2026 8:42am
Doustdar

Novo CEO accepts ‘couple of setbacks,’ hunts for bolt-on deals

Aug 5, 2026 8:00am
Novo Nordisk

Novo Nordisk fails to dismiss lawsuit over CagriSema readout

Jul 29, 2026 10:30am
Pharma money pharma money pharma profits Big Pharma sales drug sales
Favicon Fierce Pharma

Obesity meds, China drive $2T in projected 2032 drug sales: report

Jun 23, 2026 9:00am
Mike Doustdar Novo Nordisk Novo Novo CEO
Favicon Fierce Pharma

Novo Nordisk’s ‘optimistic’ CEO Doustdar sits down with Fierce

Jun 11, 2026 7:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings